Coronary Myocardial Bridge and Coronary Plaques on MDCT

November 3, 2026 updated by: Abdelaziz Aly Mohamed, Sohag University

The Prevalence of Coronary Myocardial Bridge on Multidetector Computed Tomography and Its Relation to Coronary Plaques

Myocardial bridging is a condition in which a segment of a coronary artery passes through the heart muscle instead of running on its surface. This study aims to determine the prevalence of coronary myocardial bridging and investigate its relationship with coronary atherosclerotic plaques using multidetector computed tomography coronary angiography (MDCT-CA).

The study will include at least 50 patients referred for coronary CT angiography at Sohag University Hospital and New Sohag University Hospital. CT images will be evaluated to identify myocardial bridges, determine their location, measure their length and depth, and assess the presence, location, and characteristics of coronary atherosclerotic plaques.

The findings will be analyzed to investigate the association between myocardial bridging and coronary atherosclerotic plaques.

Study Overview

Status

Recruiting

Detailed Description

Myocardial bridging is an anatomical variant characterized by an intramyocardial course of a segment of an epicardial coronary artery. Although it is frequently considered a benign finding, several studies have suggested an association between myocardial bridging and coronary atherosclerotic plaque formation, particularly in the coronary segment proximal to the bridged segment.

This prospective observational study aims to determine the prevalence of coronary myocardial bridging using multidetector computed tomography coronary angiography (MDCT-CA) and investigate its relationship with coronary atherosclerotic plaques.

The study will be conducted at the Diagnostic and Interventional Radiology Departments of Sohag University Hospital and New Sohag University Hospital. At least 50 patients referred for coronary CT angiography will be included, without age or sex restrictions.

Coronary CT angiography examinations will be performed using 128-row or 160-row multidetector CT scanners. The imaging protocol will include coronary calcium scoring and contrast-enhanced coronary CT angiography with electrocardiographic gating.

The coronary arteries, including the right coronary artery, left main coronary artery, left anterior descending artery, and left circumflex artery, will be evaluated for the presence of myocardial bridging and coronary atherosclerotic plaques.

For each detected myocardial bridge, the following parameters will be assessed:

  • Involved coronary artery and anatomical location.
  • Length of the bridged segment, measured from its entry into the myocardium to its re-emergence onto the epicardial surface.
  • Depth of the myocardial bridge, measured as the maximum thickness of the overlying myocardial fibers.

Coronary atherosclerotic plaques will be assessed regarding their presence, location, and characteristics. The findings will subsequently be analyzed to investigate the relationship between myocardial bridging and coronary atherosclerotic plaques.

The collected data will be statistically analyzed to determine the prevalence of myocardial bridging and evaluate its association with coronary atherosclerotic plaques.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sohag Governorate
      • Sohag, Sohag Governorate, Egypt
        • Recruiting
        • Sohag University Hospital
        • Contact:
        • Contact:
          • Amr Mostafa Kadry
          • Phone Number: 201005356935

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of patients referred to the Diagnostic and Interventional Radiology Department at Sohag University Hospital and New Sohag University Hospital to undergo coronary CT angiography. At least 50 patients of both sexes, without age restrictions, will be included in this prospective observational study to assess the prevalence of coronary myocardial bridging and its relationship with coronary atherosclerotic plaques.

Description

Inclusion Criteria:

  • All patients referred to the Radiology Department of Sohag University Hospital and New Sohag University Hospital for coronary CT angiography.

Exclusion Criteria:

  • Patients with contraindications to CT examination due to radiation-related risks.
  • Patients with known allergy to iodinated contrast media or impaired renal function (serum creatinine > 1.5 mg/dL or estimated glomerular filtration rate < 30 mL/min).
  • Patients with heart rate or rhythm incompatible with electrocardiographically gated scanning (heart rate > 70 beats/min or uncontrolled atrial fibrillation).
  • Patients with an Agatston calcium score > 400.
  • Uncooperative patients or those who do not provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with Prevalence of Coronary Myocardial Bridging
Time Frame: Day 1 (At the time of coronary CT angiography examination"

Determination of the prevalence of coronary myocardial bridging among patients undergoing multidetector computed tomography coronary angiography (MDCT-CA), based on the identification of intramyocardial coronary artery segments.

Day 1 (At the time of coronary CT angiography examination"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

October 30, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 4, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared with other researchers to maintain patient confidentiality and protect personal information. Study results may be disseminated in scientific publications in aggregate form without identifying individual participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe